You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 8,884,098


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,884,098
Title:Expression cassettes for regulation of expression in monocotyledonous plants
Abstract: The present invention relates to expression cassettes comprising at least one transcription regulating nucleotide sequence obtainable from the group of genes of monocotyle-donous plants consisting of caffeoyl-CoA-O-methyltransferase genes, C8,7-sterol isomerase genes, hydroxyproline-rich glycoprotein (HRGP) genes, lactate dehydrogenase genes, and chloroplast protein 12 like genes. More preferably the transcription regulating sequences are obtainable from Zea mays or Oryza sativa. The transcription regulating sequences are especially useful for root/kernel-preferential, leaf/endosperm-preferential, root/silk/kernel-preferential, or constitutive expression.
Inventor(s): Song; Hee-Sook (Raleigh, NC), Morra; Marc (Bronx, NY), Dammann; Christian (Durham, NC)
Assignee: BASF Plant Science GmbH (Ludwigshafen, DE)
Application Number:11/883,996
Patent Claims:1. An expression cassette for regulating expression in a monocotyledonous plant, said expression cassette comprising: i) a promoter nucleotide sequence sharing at least 98% sequence identity to the nucleotide sequence of SEQ ID NO:1; ii) at least one nucleic acid sequence which is heterologous in relation to said promoter; and iii) a terminator comprising a nucleotide sequence sharing at least 98% sequence identity to the nucleotide sequence of SEQ ID NO:34; wherein the expression of the at least one nucleic acid sequence is constitutive.

2. The expression cassette of claim 1, further comprising the 5'-untranslated region of a plant expressed gene, or an intron from a plant expressed gene.

3. The expression cassette of claim 2, wherein the intron is from ubiquitin, actin, or alcohol dehydrogenase gene.

4. The expression cassette of claim 1, wherein the terminator comprises the nucleotide sequence of SEQ ID NO: 34.

5. A vector comprising the expression cassette of claim 1.

6. A transgenic host cell or non-human organism comprising: i) the expression cassette of claim 1; or ii) a vector comprising the expression cassette.

7. A transgenic plant comprising: i) the expression cassette of claim 1; or ii) a vector comprising the expression cassette.

8. A method for providing a transgenic expression cassette for heterologous expression in a monocotyledonous plant, said method comprising: I. isolating a promoter nucleotide sequence from a monocotyledonous plant, wherein the promoter nucleotide sequence shares at least 98% sequence identity to the nucleotide sequence of SEQ ID NO:1; II. functionally linking said promoter nucleotide sequence to another nucleotide sequence of interest, which is heterologous in relation to said promoter nucleotide sequence; and III. functionally linking said another nucleotide sequence of interest to a terminator comprising a nucleotide sequence sharing at least 98% sequence identity to the nucleotide sequence of SEQ ID NO:34.

9. The method of claim 8, wherein said terminator comprises the nucleotide sequence of SEQ ID NO: 34.

10. A cell culture, part, organ, tissue or transgenic propagation material derived from the non-human organisms of claim 6, wherein said cell culture, part, organ, tissue or transgenic propagation material comprises the expression cassette.

11. A method for the transgenic expression of a nucleic acid, said method comprising growing or culturing the non-human organisms of claim 6 or cell cultures, parts, organs, tissues or transgenic propagation material derived therefrom, wherein said cell cultures, parts, organs, tissues or transgenic propagation material comprise the expression cassette.

12. A method for identifying and/or isolating a sequence with constitutive expression activity, said method comprising: a) obtaining a polynucleotide sequence sharing at least 98% sequence identity with the nucleic acid sequence of SEQ ID NO:1; b) preparing an expression cassette comprising the polynucleotide operably linked to a reporter gene or marker and to a terminator sharing at least 98% sequence identity with the nucleic acid sequence of SEQ ID NO: 34; c) testing the expression cassette for constitutive expression; and d) identifying and/or isolating the polynucleotide with constitutive expression activity.

13. A method for directing expression in a monocotyledonous plant, said method comprising: I. introducing into a plant cell the expression cassette of claim 1, II. selecting a transgenic cell which comprises said expression cassette, and III. regenerating a plant from the transgenic cell, wherein the promoter nucleotide sequence directs constitutive expression of the nucleic acid sequence which is heterologous in relation to said promoter in the plant.

Details for Patent 8,884,098

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2025-02-09
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2025-02-09
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2025-02-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.